Biomarkers May Aid in Early Diagnosis of Alzheimer’s
New research suggests that biomarkers in the blood may help diagnose Alzheimer's disease before it progresses, potentially opening the door to better treatments.
While there are currently no treatments that can halt or delay the onset of the disease, the hope is that being able to diagnose Alzheimer's earlier could provide clues about what medication might prevent it from getting worse, the study authors said.
"Most of the research to this point has been done on those who already have Alzheimer's disease," said study author Sid O'Bryant, director of research for the F. Marie Hall Institute for Rural and Community Health at Texas Tech University Health Sciences Center. "We need to be able to identify those at greatest risk."
- CEO Exchange: Preparing for Population Health
- EHR Systems 'Immature, Costly,' AMA Says
- Better HCAHPS Scores Protect Revenue
- Advocate, NorthShore Deal Would Create 16-Hospital System
- Narrow Networks Cut Costs, Not Quality, Economists Say
- 3 Strategies for Retaining Millennial Employees
- Interstate Medical Licensure Effort Advances
- 'Early Offer' Malpractice Programs May Spur Reform
- Two NY hospitals to offer free hip and knee replacement surgeries for qualifying patients in December
- Power of price: In South FL and the nation, healthcare costs often are shrouded in secrecy